Protocol for a Randomized Crossover Trial to Evaluate the Effect of Soft Brace and Rigid Orthosis on Performance and Readiness to Return to Sport Six Months Post-ACL-Reconstruction.
Sonja JahnkeCaren CruysenRobert PrillFabian KittmannNicola PflugJustin Amadeus AlbertTibor de CamargoBert ArnrichAleksandra KrólikowskaAnna KołczPaweł ReichertLukasz OleksySven MichelSebastian KopfMichael WagnerSven SchefflerRoland BeckerPublished in: Healthcare (Basel, Switzerland) (2023)
A randomized crossover trial was designed to investigate the influence of muscle activation and strength on functional stability/control of the knee joint, to determine whether bilateral imbalances still occur six months after successful anterior cruciate ligament reconstruction (ACLR), and to analyze whether the use of orthotic devices changes the activity onset of these muscles. Furthermore, conclusions on the feedforward and feedback mechanisms are highlighted. Therefore, twenty-eight patients will take part in a modified Back in Action (BIA) test battery at an average of six months after a primary unilateral ACLR, which used an autologous ipsilateral semitendinosus tendon graft. This includes double-leg and single-leg stability tests, double-leg and single-leg countermovement jumps, double-leg and single-leg drop jumps, a speedy jump test, and a quick feet test. During the tests, gluteus medius and semitendinosus muscle activity are analyzed using surface electromyography (sEMG). Motion analysis is conducted using Microsoft Azure DK and 3D force plates. The tests are performed while wearing knee rigid orthosis, soft brace, and with no aid, in random order. Additionally, the range of hip and knee motion and hip abductor muscle strength under isometric conditions are measured. Furthermore, patient-rated outcomes will be assessed.
Keyphrases
- anterior cruciate ligament reconstruction
- end stage renal disease
- study protocol
- skeletal muscle
- randomized controlled trial
- clinical trial
- open label
- phase iii
- chronic kidney disease
- total knee arthroplasty
- phase ii
- newly diagnosed
- ejection fraction
- stem cells
- bone marrow
- type diabetes
- mass spectrometry
- adipose tissue
- peritoneal dialysis
- weight loss
- glycemic control